HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hepatitis B reactivation after tenofovir withdrawal in an HIV-infected patient with history of cured hepatitis B virus infection and poor immunological status.

AuthorsRafael Mican, Carmen Busca Arenzana, Julia Vasquez, German Daroca, Ignacio Perez-Valero, Luz Martin-Carbonero
JournalAIDS (London, England) (AIDS) Vol. 35 Issue 10 Pg. 1707-1708 (08 01 2021) ISSN: 1473-5571 [Electronic] England
PMID34270493 (Publication Type: Journal Article)
Chemical References
  • Antiviral Agents
  • Hepatitis B Antibodies
  • Tenofovir
Topics
  • Antiviral Agents (adverse effects)
  • HIV Infections (complications, drug therapy)
  • Hepatitis B (complications, drug therapy)
  • Hepatitis B Antibodies
  • Hepatitis B virus
  • Hepatitis B, Chronic (complications, drug therapy)
  • Humans
  • Tenofovir (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: